Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2568
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis ; day:4 ; month:2 ; year:2023 ; pages:1-11
Digestive diseases and sciences ; (4.2.2023), 1-11
- Creator
-
Lichtenstein, Gary R.
Cohen, Benjamin L.
Salese, Leonardo
Modesto, Irene
Wang, Wenjin
Chan, Gary
Ahmed, Haytham Mohamed
Su, Chinyu
Peyrin-Biroulet, Laurent
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10620-022-07794-0
- URN
-
urn:nbn:de:101:1-2023040909044281671755
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lichtenstein, Gary R.
- Cohen, Benjamin L.
- Salese, Leonardo
- Modesto, Irene
- Wang, Wenjin
- Chan, Gary
- Ahmed, Haytham Mohamed
- Su, Chinyu
- Peyrin-Biroulet, Laurent
- SpringerLink (Online service)
Other Objects (12)
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia